Análise crítica das novas recomendações para reanimação cardiopulmonar

Abstract

Objective: To describe the new American Heart Association (AHA) guidelines for pediatric life support, based on the scientific evidence evaluated by the International Liaison Committee on Resuscitation, and endorsed and disseminated by North American resuscitation councils. Sources: The guidelines for basic and advanced life support published in Circulation in November 2005 were reviewed together with subsequent publications on the same topics, identified in PubMed and MEDLINE using the keywords cardiac arrest, basic life support, advanced life support, cardiopulmonary resuscitation and pediatric resuscitation. Summary of the findings: The greatest guideline changes are in the area of basic life support. The new guidelines emphasize the new chest compression/ventilation ratio for trained health professionals, which is now 15:2 for all children except neonates. Also emphasized is the need for harder and faster chest compressions, and the need to avoid hyperventilation during and after cardiorespiratory arrest. The use of high-dose epinephrine has been removed, as have some other previous recommendations. Conclusions: The most recent AHA guidelines for pediatric resuscitation are focused primarily on basic life support care. They are based on the best available scientific evidence, although further research is required to validate these changes and provide new evidence for future guidelines.

A atuação do fisioterapeuta no time de resposta rápida em um hospital de alta e média complexidade na Amazônia

“…Bellan, Araújo e Araújo [7] afirmam que as habilidades e os conhecimentos de como agir frente a um quadro de PCR por profissionais da área da saúde ainda são insuficientes. O sucesso no atendimento e a reversão do quadro irão depender do conhecimento dos membros da equipe quanto a suas funções e seus reais objetivos, sendo eles, compressões na caixa torácica, manter ventilação pulmonar, tratar as causas etiológicas de cada modalidade de PCR, entre outros [8,9].…”